https://doi.org/10.5812/iji.14230

Molecular Assay of Staphylococcal Enterotoxin E in Synovial Fluid of Patients with Rheumatoid Arthritis

authors:

avatar Mahdi Rashki 1 , avatar Ramezan Ali Ataee ORCID 1 , * , avatar Gholam Hossien Alishiri 2 , avatar Davoode Esmaeili 1

Department of Medical Microbiology, Faculty of Medicine, Baqiyatallah University of Medical Sciences, Tehran, Iran
Department of Rheumatology, Faculty of Medicine, and Hospital Research Development Committee, Baqiyatallah University of Medical Sciences, Tehran, IR Iran
International Journal of Infection: Vol.5, issue 1; e14230
published online: January 9, 2018
article type: Research Article
received: July 22, 2017
revised: August 20, 2017
accepted: September 13, 2017

how to cite: Rashki M, Ataee R A, Alishiri G H, Esmaeili D. Molecular Assay of Staphylococcal Enterotoxin E in Synovial Fluid of Patients with Rheumatoid Arthritis. Int J Infect. 2018;5(1):e14230. https://doi.org/10.5812/iji.14230.

Abstract

Background:

The role of Staphylococcal enterotoxin E (Superantigen E) in rheumatoid arthritis pathogenesis has been considered. This paper aimed at determining Staphylococcal enterotoxin E in the synovial fluid of rheumatoid arthritis patients.

Methods:

In this study, 100 synovial fluid samples of patients with rheumatoid arthritis were examined. The primers pairs were designed based on the S. baureus enterotoxin type E (entE) gene, GenBank: M21319.1. All samples were subjected to DNA extraction separately. Then, polymerase chain reaction (PCR) was implemented. Data were analyzed by descriptive statistics.

Results:

The PCR results indicated that Staphylococcal enterotoxin E gene existed in synovial fluid samples of 25% of patients with rheumatoid arthritis, with a high percentage.

Conclusions:

The study results revealed that a high percentage of patients with rheumatoid arthritis have Staphylococcal enterotoxin type E gene in their synovial fluid. However, further studies are needed to assess other Staphylococcal enterotoxins. This finding may provide a model for diagnosing rheumatoid arthritis disease. The results of this study have presented some evidence regarding endogenous origin of involved superantigen in patients with rheumatoid arthritis.

1. Background

The investigation of rheumatoid arthritis (RA) cases has revealed that the disease has been a public health concern considering the rising cost trends, its incidence, and disability. Many related researches have been conducted (1). The conclusion of the current investigations showed that RA plays the role of an autoimmune disease in a way that the existence of an antigen or superantigen causes pathological immune reaction. These antigens or superantigens are MHC type II positive cell classification up to CD4 T cells (2). Staphylococcal superantigens (enterotoxins) have been implicated in the pathogenesis of inflammatory diseases. Antigens, which have been generated by Staphylococcus aureus (S. aureus), are classified into the most lethal toxins that rise a toxic shock by destructing a cellular immune response. Chemokines, which are very tiny, have an important role in arthritis (3, 4). Chemoattractant cytokines have an effect in gathering all inflammatory cells near the inflammation (5). Schutyser et al. reported that the monocytic cells react to Gram-positive bacterial infection by CCL18/PARC generation (chemokine ligand 18/pulmonary and activation regulated chemokine) in the synovial cavity (6). Recently, the antagonist activity of this peptide has been identified as the novel domain in superantigens, which is critical for their toxic action (7, 8).

The Staphylococcal enterotoxins (SEs) are superantigens that can disable the T-cell activation and proliferation; their action form is more likely linked to cytokine release action and cell death through apoptosis and some other toxic shock syndrome, which can have a roll of a potentially lethal toxin. Although we could classify SEs superantigen activities, the source of action mode, which causes emesis and diarrhea, has not been yet characterized (9).

It is not reliable to take T-cells proliferation into account as the source of TSST-1, but instead, other host cells receptors should be considered. It was reported that chemokines release is activated by TSST-1 stimulation, like IL-8 and MIP-3a, IL-2, and TNFa (10, 11).

However, PCR (polymerase chain reaction), based on molecular techniques, has led to an increase in diagnosis of bacterial etiologies for clinical specimens with negative bacterial culture (12, 13). Several investigations have also been done to examine the PCR technique for standardization detection of Staphylococcal enterotoxins in body fluids of patients (14-17). In this study, we aimed at detecting Staphylococcal enterotoxin E in synovial fluids of patients with rheumatoid arthritis.

2. Methods

S. aureus has entE gene, the main factor of enterotoxin E, which was isolated from clinical samples and used as positive control (18). The primers pairs were designed based on the reference sequence of the S. aureus enterotoxin type E (entE) gene, GenBank: M21319.1, using online Gene script software. Then, they were analyzed by Primer3 software. In addition, multiple alignments were performed by DNASIS MAX trial version. The final sequence of designed primer pairs was as follows: TCATTGCCCTAACGTTGACA and R CTTACCGTGGACCCTTCAGA.

From April 2011 to August 2013, a total of 100 synovial fluid samples were collected from the patients with RA by rheumatologists and kept at -80°C until used. The criteria for adding or removing a patient were based on ACR 2010 criteria.

The fulfilling of the sampling process by the complete observance of aseptic conditions was based on the microbial standard protocol; 5 to 10 mL synovial fluid was taken from the disinfecting samples using a syringe. Then, 3 to 5 mL was injected into Castaneda medium (BAHARAFSHAN Co, Tehran, Iran) and incubated for 48 hours at 37°C. To perform PCR, DNA was extracted from bacteria as positive control, and then, bacterial standard strain was injected into 5 mL LB and incubated for 24 hours at 37°C. DNA was extracted by cellular sediments and a method named salting-out (14). For DNA extraction from synovial fluid, 100 µL of synovial fluid was picked and injected into DNA- free sterile tube. In the later stage, using a Cinapure DNA extraction kit (CinnaGen Co, thehran Iran), each of the synovial fluid genomes was extracted in isolation. Based on the kit instruction, a volume sized equal to 100 µL (microlitter) was added to the kit’s tube; then, 400 µL of some buffer called lysis was added to suspension and whirlpooled about 20 seconds; afterwards, 300 µL of precipitation was added to the microtube and whirlpooled once more for 5 seconds. At this point, all components were centrifuged (1 minute, 5°C, 13000 × g). Then, we switched to a new microtube and washed the column with 400 µL of buffer number 1 and centrifuged it once more (1 minute, 5°C, 12000 × g). After switching the column itself to a new one, 30 µL of elution buffer was added and centrifuged 5 minutes, 12000 × g). In the last stage, we measured its quality and quantity by NanoDrop (thermo scientific NanoDrop 2000 Spectrophotometer, USA).

To amplify the DNA, a mixture was prepared in 200 µL using a mixture, which would respond to the volume of 25 µL in a sparking rate, which contains 2 µL to assure the amount of 2 µL, 0.3 U from Taq DNA polymerase, buffer size of 2.5 µL of type 10x PCR as well as 0.16 mM of each dNTPs, 2 mM MgCl2 (all indexes were from Cinagen company, Iran ), 10 pmol of initial pair (mingled by Cinagen) and doubled-stilled water to a final amount of 25 µL. All the same amplifications were done in a thermal process by a thermocycler (Bio-Rad, C1000) with deprivation at 95°C, a 3- minute time interval for 35 cycles at 94°C for 30 seconds, and initial heating at 72°C for 5 minutes. The PCR products, which help amplification, have been electrophoresed in a process lasting for 45 minutes, and were then colored with a substance named ethidium bromide or cyber green day in 20 minutes (0.05 mg/mL; Sigma Aldrich). By employing ultraviolet light, the gel was photographed by gel documentation (Bio-Rad universal hood II, USA). In addition, molecular dimensions were in every agarose gel. In the last stage, using an optimization PCR, all samples of synovial fluid were examined separately.

3. Results

At last, the yielded results indicated that the initial design sequence played a role in amplification of 725 bp amplicons like a product used as PCR. Based on the information related to species genome and the components from master mix, PCR has been improved precisely and employed as a positive aspect of control. Examination of the samples revealed that the PCR method is able to detect entE gene in 25% of patients’ synovial fluid. Figure 1 displayed the results of PCR product, presenting electrophoresed samples related to synovial fluid of patients with RA. The amplicon 725 bp fragments for a number of SF samples were characterized and sequenced.

The Result of Agarose Gel Electrophoresis of PCR Product
The Result of Agarose Gel Electrophoresis of PCR Product
Figure 1.

The Result of Agarose Gel Electrophoresis of PCR Product

Figure 1 that the first line is 50 MW marker, lines 1, 2, 3, 7, 8, 11, 12, and 13 are shown as 725 bp fragments (partial entE Gene). Lines 4, 6, 9, and 10 are used as negative control and line 5 as positive control.

4. Discussion

The results of this study revealed the existence of Staphylococcal enterotoxin E gene with the frequency of 25% in synovial fluid samples of patients with RA.

Zahiri Y et al. in their study, examined Staphylococcal enterotoxin E gene in blood samples of patients with rheumatoid arthritis disease. Just 5 bacterial species were isolated, of which one case was found to have Staphylococcus aureus bacterium, based on biochemical test results. The results obtained from molecular examinations revealed the existence of 13.25% of enterotoxin E gene (19). However, in this study, the results were associated with 25% positive Staphylococcal E gene. The differences may be related to the origin of samples. In fact, these reports are among the first published researches results. Zahiri Y et al. reported S.aureus entE in the blood of patients with RA, while this toxin gene was present in the SF of RA patients. However, many studies have been done on the toxigenicity of isolated S. aureus strain from patients (17), foods materials (20), and even on environmental isolated (21). As an example, Rahimi conducted a study to characterize the outbreak linked to enterotoxin producing S. aureus species in uncooked meat and hamburgers in Isfahan province, Iran. Nearly, 223 (60%) of S. aureus were isolated and diagnosed, and among them, 13.5% (equal to 30 strains) were recognized to be enterotoxigenic. Surprisingly, 86% of them (equal to 26 strains) were positive just against one type (14 SEA, 1 SEB, 6 SEC and 5 SED), while the rest were playing a role as positive ones against more than one SEs. None of the isolated ones were positive against SEE (22).

The study results of Arwa and Humodi revealed that the prevalence of enterotoxin A, B, C in the hands of the tested people was 48 strains (29%) of S. aureus. Of the 48 strains, 9 (18.7%) had entrotoxin A gene and 7 (14.5%) had entrotoxin B and C gene (23).

The results of another study revealed that the prevalence of S. aureus toxins was as follows: enterotoxin A: 23.08%; enterotoxin B: 30.77%%; enterotoxin C: 15.38%; enterotoxin D: 15.38%; and enterotoxin C and A 15.38% (24). Superantigens, such as Staphylococcal enterotoxins, play a major role in inflammatory disease. The results of a study (25) raised a question: Where these enterotoxins enter to SF? Thus, this study was performed to answer this question. The results of the present study showed that a high percentage of patients with rheumatoid arthritis had enterotoxin E gene in their synovial fluid. These findings may demonstrate the role of e enterotoxin as a superantigen to induce rheumatoid arthritis. In addition, the PCR technique is highly recommended as a fast method for the detection of enterotoxin E gene in the synovial fluid. However, further studies should also be conducted. Staphylococcal enterotoxin E gene detection as a model may be used for the diagnosis and modification of treatment of rheumatoid arthritis disease.

Acknowledgements

References

  • 1.

    Seror R, Pagnoux C, Guillevin L. Plasma exchange for rheumatoid arthritis. Transfus Apher Sci. 2007;36(2):195-9. [PubMed ID: 17499763]. https://doi.org/10.1016/j.transci.2007.01.005.

  • 2.

    Zangerle PF, De Groote D, Lopez M, Meuleman RJ, Vrindts Y, Fauchet F, et al. Direct stimulation of cytokines (IL-1 beta, TNF-alpha, IL-6, IL-2, IFN-gamma and GM-CSF) in whole blood: II. Application to rheumatoid arthritis and osteoarthritis. Cytokine. 1992;4(6):568-75. [PubMed ID: 1292640].

  • 3.

    Parsonnet J, Hansmann MA, Delaney ML, Modern PA, Dubois AM, Wieland-Alter W, et al. Prevalence of toxic shock syndrome toxin 1-producing Staphylococcus aureus and the presence of antibodies to this superantigen in menstruating women. J Clin Microbiol. 2005;43(9):4628-34. [PubMed ID: 16145118]. https://doi.org/10.1128/JCM.43.9.4628-4634.2005.

  • 4.

    Durand G, Bes M, Meugnier H, Enright MC, Forey F, Liassine N, et al. Detection of new methicillin-resistant Staphylococcus aureus clones containing the toxic shock syndrome toxin 1 gene responsible for hospital- and community-acquired infections in France. J Clin Microbiol. 2006;44(3):847-53. [PubMed ID: 16517865]. https://doi.org/10.1128/JCM.44.3.847-853.2006.

  • 5.

    Floret D. Clinical aspects of streptococcal and staphylococcal toxinic diseases. Arch Pediatr. 2001;8 Suppl 4:762-8. [PubMed ID: 11582925].

  • 6.

    Schutyser E, Struyf S, Wuyts A, Put W, Geboes K, Grillet B, et al. Selective induction of CCL18/PARC by staphylococcal enterotoxins in mononuclear cells and enhanced levels in septic and rheumatoid arthritis. Eur J Immunol. 2001;31(12):3755-62. [PubMed ID: 11745396]. https://doi.org/10.1002/1521-4141(200112)31:12<3755::AID-IMMU3755>3.0.CO;2-O.

  • 7.

    Kaempfer R. Peptide antagonists of superantigen toxins. Mol Divers. 2004;8(2):113-20. [PubMed ID: 15209162].

  • 8.

    Kaempfer R, Arad G, Levy R, Hillman D. Defense against biologic warfare with superantigen toxins. Isr Med Assoc J. 2002;4(7):520-3. [PubMed ID: 12120463].

  • 9.

    Betley MJ, Schlievert PM, Bergdoll MS, Bohach GA, Iandolo JJ, Khan SA, et al. Staphylococcal gene nomenclature. ASM News. 1990;56:182.

  • 10.

    Otto M. Staphylococcus aureus toxins. Curr Opin Microbiol. 2014;17:32-7. [PubMed ID: 24581690]. https://doi.org/10.1016/j.mib.2013.11.004.

  • 11.

    Stach CS, Herrera A, Schlievert PM. Staphylococcal superantigens interact with multiple host receptors to cause serious diseases. Immunol Res. 2014;59(1-3):177-81. [PubMed ID: 24838262]. https://doi.org/10.1007/s12026-014-8539-7.

  • 12.

    Rosey AL, Abachin E, Quesnes G, Cadilhac C, Pejin Z, Glorion C, et al. Development of a broad-range 16S rDNA real-time PCR for the diagnosis of septic arthritis in children. J Microbiol Methods. 2007;68(1):88-93. [PubMed ID: 16904782]. https://doi.org/10.1016/j.mimet.2006.06.010.

  • 13.

    van der Heijden IM, Wilbrink B, Vije AE, Schouls LM, Breedveld FC, Tak PP. Detection of bacterial DNA in serial synovial samples obtained during antibiotic treatment from patients with septic arthritis. Arthritis Rheum. 1999;42(10):2198-203. [PubMed ID: 10524694]. https://doi.org/10.1002/1529-0131(199910)42:10<2198::AID-ANR23>3.0.CO;2-N.

  • 14.

    Ataee RA, Kamali M, Karami A, Ghorbani M. Standardization of molecular method detection of the entC in staphylococcus aureus isolated from human infections and determine its sequence. Iran J Mil Med. 2012;14(3):232-40.

  • 15.

    Ataee RA, Karami A, Sorory R, Baghery MK. Standardization of molecular diagnostic of th ent D Staphylococcus aureus isolated from human infections and sequence determination. Sci J Zanjan Univ Med Sci. 2012;20(78):1-12.

  • 16.

    Ataee RA, Karami A, Izadi M, Aghania A, Ataee MH. Molecular screening of staphylococcal enterotoxin B gene in clinical isolates. Cell J. 2011;13(3):187-92. [PubMed ID: 23508641].

  • 17.

    Ataee RA, Mehrabi-Tavana A, Izadi M, Hosseini SM, Ataee MH. Bacterial meningitis: a new risk factor. J Res Med Sci. 2011;16(2):207-10. [PubMed ID: 22091233].

  • 18.

    Ataee RA, Esmaeili D, Khanshan RM. Heterologous expression of staphylococcal enterotoxin E gene. J Pure Appl Microbiol. 2013;7(2):957-63.

  • 19.

    Zahiri Yeganeh S, Ataee RA, Alishiri GH, Movahedi M. Bacteriological and molecular assessment of staphylococcal enterotoxin E in the blood of patients with rheumatoid arthritis. Jundishapur J Microbiol. 2015;8(2):16621. [PubMed ID: 25793096]. https://doi.org/10.5812/jjm.16621.

  • 20.

    Peyravii F, Kermanshi RK, Ataee RA, Akhavan Sepahi A, Ghaemi EA. Molecular frequency of enterotoxigenic staphylococcus aureus among different isolated of food products. HealthMed. 2013;7(7):2105-9.

  • 21.

    Becker K, Roth R, Peters G. Rapid and specific detection of toxigenic Staphylococcus aureus: use of two multiplex PCR enzyme immunoassays for amplification and hybridization of staphylococcal enterotoxin genes, exfoliative toxin genes, and toxic shock syndrome toxin 1 gene. J Clin Microbiol. 1998;36(9):2548-53. [PubMed ID: 9705390].

  • 22.

    Rahimi E, Nonahal F, Ataye Salehi E. Detection of classical enterotoxins of staphylococcus aureus strains isolated from raw meat in Esfahan, Iran. Health Scope. 2013;2(2):95-8. https://doi.org/10.17795/jhealthscope-10651.

  • 23.

    Arwa OH, Humodi AS. Enterotoxigenic staphylococcus aureus amongst food handlers in Khartoum state, Sudan. Eur Acad Res. 2016;4(4):3453-65.

  • 24.

    Dablool AS. Isolation of enterotoxin producing S. areus from hospital food handlers, makkah, Saudi Arabia. Eur Acad Res. 2014;2(1):475-83.

  • 25.

    Ataee RA, Alishiri GH, Mohoseni Moghadam Z, Latifi AM, Ataee MH. Enzyme linked immunosorbent assay for detection staphylococcal enterotoxins in synovial fluid of heumatoid arthritis patients. J Pure Appl Microbiol. 2013;7(2):1113-9.